Biogen Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Analysis

Biogen, Inc. (BIIB)

193.08 -0.68 (-0.35%) USD | NASDAQ | May 26, 16:00

193.99 +0.91 (+0.47%) Pre-Market: 08:25

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) for BIIB.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Benchmarks

Start Trial

Amgen, Inc.	Upgrade
Gilead Sciences, Inc.	Upgrade
AbbVie, Inc.	Upgrade
Apellis Pharmaceuticals, Inc. (DELISTED)	Upgrade
Moderna, Inc.	Upgrade